Circulating Peptidome to Indicate the Tumor-resident Proteolysis

分类： 生物学 >> 生物物理学 提交时间： 2016-05-12

Deng, Zaian Zhang, Yaou Cai, Guoping Deng, Zaian Li, Yaojun Fan, Jia Wang, Guohui Shen, Haifa Ferrari, Mauro Hu, Tony Y. Deng, Zaian Zhang, Yaou Cai, Guoping Li, Yan Shen, Haifa Hu, Tony Y. Ferrari, Mauro

摘要： Tumor-resident proteases (TRPs) are regarded as informative biomarkers for staging cancer progression and evaluating therapeutic efficacy. Currently in the clinic, measurement of TRP is dependent on invasive biopsies, limiting their usefulness as monitoring tools. Here we identified circulating peptides naturally produced by TRPs, and evaluated their potential to monitor the efficacy of anti-tumor treatments. We established a mouse model for ovarian cancer development and treatment by orthotopic implantation of the human drug-resistant ovarian cancer cell line HeyA8-MDR, followed by porous silicon particle-or multistage vector (MSV) -enabled EphA2 siRNA therapy. Immunohistochemistry staining of tumor tissue revealed decreased expression of matrix metallopeptidase 9 (MMP-9) in mice exhibiting positive responses to MSV-EphA2 siRNA treatment. We demonstrated, via an ex vivo proteolysis assay, that C3f peptides can act as substrates of MMP-9, which cleaves C3f at L-1311-L-1312 into two peptides (SSATTFRL and LWENGNLLR). Importantly, we showed that these two C3f-derived fragments detected in serum were primarily generated by tumor-resident, but not blood-circulating, MMP-9. Our results suggested that the presence of the circulating fragments specially derived from the localized cleavage in tumor microenvironment can be used to evaluate therapeutic efficacy of anti-cancer treatment, assessed through a relatively noninvasive and user-friendly proteomics approach.

同行评议状态:待评议

 点击量 4031  下载量 1524  评论